Company
Headquarters: Hsinchu City, Taiwan
CEO: Mr. T.C. Lin
TW$1.51 Billion
TWD as of Jan. 1, 2024
US$49.2 Million
| Company | Market Cap (USD) |
|---|---|
| Zoetis Inc. | $89.09 B |
| MERCK Kommanditgesellschaft auf Aktien | $67.64 B |
| Takeda Pharmaceutical Company Limited | $47.71 B |
| Haleon plc | $38.90 B |
| PPD, Inc. | $16.58 B |
| Company | Market Cap (USD) |
|---|---|
| Lilly | $586.39 B |
| UnitedHealth Group | $504.47 B |
| Novo Nordisk | $461.52 B |
| Johnson & Johnson | $387.50 B |
| Merck | $296.51 B |
General Biologicals Corporation engages in manufacturing and selling in-vitro diagnostic devices and pharmaceuticals in Taiwan and internationally. It offers real-time PCR products, including IVD kits and genesis products for breast cancer; ELISA Products comprising KIWI products; RIA products for gastrin, hepatitis, and thyroid, as well as vitamin products; rapid tests consisting of blood glucose monitoring systems, and cardiac and tumor markers, as well as products related to drug abuse, fertility hormones, and infectious diseases; lab ware products; and raw materials that comprise antibodies and antigens. The company also provides protein drugs for oral candidiasis; and point of care products for liver fibrosis and breast cancer indications. In addition, it offers products for use in clinics and laboratories for preventives and cancer diagnosis, including skin and oral care, breast cancer and liver related, and advanced cancer diagnosis products, as well as healthcare and education services. General Biologicals Corporation was founded in 1984 and is headquartered in Hsinchu City, Taiwan.
Top 1-year algo backtest: +269.94%
$10,000 in May 2023 would now be $36,994 by following this algorithm daily at market close.
Boost your stocks returns with Disfold AI... Now!
Try Disfold AI for FREE
General Biologicals Corp has the following listings and related stock indices.
Stock: TWSE: 4117 wb_incandescent